section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Tested in dextrose 5%, Ringer’s injection, lactated, sodium chloride 0.45%, and sodium chloride 0.9%.

e Tested as the premixed infusion solution.

f Lyophilized formulation tested.

g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

h A 32.5-mL sample of parenteral nutrition solution combined with 50 mL of antibiotic solution.

i Run at 21 mL/hr.

j Given over five minutes by syringe pump.

k Run at 94 mL/hr.

l Tested in sterile water for injection.

m Test performed using the formulation WITHOUT edetate disodium.

n Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

o Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

p Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

q Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

r Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

s Test performed using the formulation WITH edetate disodium.